Introduction: Available studies show conflicting results on the relationship between smoking characteristics (age at beginning, importance of consumption) and disease characteristics (disease onset, phenotype, and severity). The objective of the study was to better understand the influence of smoking on hidradenitis suppurativa (HS) characteristics. Methods: The clinical characteristics and smoking habits of 1,689 HS patients were assessed and compared between never, past, and active smokers using Student’s t, Fisher’s exact, and χ2 tests. Association analyses were done using Spearman’s method and logistic regressions. Results: There was a positive association between the mean age at smoking onset and the mean age at HS onset (ρ = 0.4; p < 0.001). Smokers were associated with a more severe disease: the number of affected sites was positively associated with the number of pack-years (ρ = 0.126, p = 0.0002). There was also a significant association between active smoking and a poorer quality of life (p < 0.001), as well as increased pain during HS flares (p < 0.003). Conclusion: Smoking early is associated to earlier onset of HS and heavy HS smokers develop a more severe disease in a dose-response manner. These results may support evidence-based counseling efforts for smoking cessation in HS patients and patients at risk of HS.

There are gaps in our understanding of the influence of tobacco smoking in disease onset and activity in hidradenitis suppurativa (HS). Our results are in favor of smoking directly influencing HS onset, HS phenotype, and disease severity in a dose-response manner. This study suggests that smoking cessation should be systematically promoted in HS patients.

1.
Breitkopf
C
,
Bockhorst
J
,
Lippold
A
,
Ernst
K
,
Hundeiker
M
.
Pyodermia fistulans sinifica (Akne inversa) und Rauchgewohnheiten
.
H&G Zeitschrift fur Hautkrankheiten
.
1995
;
70
:
332
4
.
2.
Acharya
P
,
Mathur
M
.
Hidradenitis suppurativa and smoking: a systematic review and meta-analysis
.
J Am Acad Dermatol
.
2020
;
82
(
4
):
1006
11
.
3.
Garg
A
,
Malviya
N
,
Strunk
A
,
Wright
S
,
Alavi
A
,
Alhusayen
R
, et al
.
Comorbidity screening in hidradenitis suppurativa: evidence-based recommendations from the US and Canadian hidradenitis suppurativa foundations
.
J Am Acad Dermatol
.
2022
;
86
(
5
):
1092
101
.
4.
Ozkur
E
,
Karadag
AS
,
Ustuner
P
,
Aksoy
B
,
Esme
P
,
Caliskan
E
, et al
.
Clinical and demographic features of hidradenitis suppurativa: a multicentre study of 1221 patients with an analysis of risk factors associated with disease severity
.
Clin Exp Dermatol
.
2020
;
46
(
3
):
532
540
.
5.
Dessinioti
C
,
Zisimou
C
,
Tzanetakou
V
,
Ntritsos
G
,
Kontochristopoulos
G
,
Antoniou
C
.
A retrospective institutional study of the association of smoking with the severity of hidradenitis suppurativa
.
J Dermatol Sci
.
2017
;
87
(
2
):
206
7
.
6.
Sartorius
K
,
Emtestam
L
,
Jemec
GB
,
Lapins
J
.
Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity
.
Br J Dermatol
.
2009
;
161
(
4
):
831
9
.
7.
Vazquez
BG
,
Alikhan
A
,
Weaver
AL
,
Wetter
DA
,
Davis
MD
.
Incidence of hidradenitis suppurativa and associated factors: a population-based study of Olmsted County, Minnesota
.
J Invest Dermatol
.
2013
;
133
(
1
):
97
103
.
8.
Liakou
AI
,
Kontochristopoulos
G
,
Marnelakis
I
,
Tsantes
AG
,
Papadakis
M
,
Alevizou
A
, et al
.
Thyroid disease and active smoking may Be associated with more severe hidradenitis suppurativa: data from a prospective cross sectional single-center study
.
Dermatology
.
2021
;
237
(
1
):
125
30
.
9.
Schrader
AM
,
Deckers
IE
,
van der Zee
HH
,
Boer
J
,
Prens
EP
.
Hidradenitis suppurativa: a retrospective study of 846 Dutch patients to identify factors associated with disease severity
.
J Am Acad Dermatol
.
2014
;
71
(
3
):
460
7
.
10.
Yang
JH
,
Moon
J
,
Kye
YC
,
Kim
KJ
,
Kim
MN
,
Ro
YS
, et al
.
Demographic and clinical features of hidradenitis suppurativa in Korea
.
J Dermatol
.
2018
;
45
(
12
):
1389
95
.
11.
Omine
T
,
Miyagi
T
,
Hayashi
K
,
Yamaguchi
S
,
Takahashi
K
.
Clinical characteristics of hidradenitis suppurativa patients in okinawa, Japan: differences between east asia and western countries
.
J Dermatol
.
2020
;
47
(
8
):
855
62
.
12.
Katoulis
AC
,
Liakou
AI
,
Rotsiamis
N
,
Bonovas
S
,
Bozi
E
,
Rallis
E
, et al
.
Descriptive epidemiology of hidradenitis suppurativa in Greece: a study of 152 cases
.
Skin Appendage Disord
.
2017
;
3
(
4
):
197
201
.
13.
Canoui-Poitrine
F
,
Revuz
JE
,
Wolkenstein
P
,
Viallette
C
,
Gabison
G
,
Pouget
F
, et al
.
Clinical characteristics of a series of 302 French patients with hidradenitis suppurativa, with an analysis of factors associated with disease severity
.
J Am Acad Dermatol
.
2009
;
61
(
1
):
51
7
.
14.
König
A
,
Lehmann
C
,
Rompel
R
,
Happle
R
.
Cigarette smoking as a triggering factor of hidradenitis suppurativa
.
Dermatology
.
1999
;
198
(
3
):
261
4
.
15.
Garg
A
,
Papagermanos
V
,
Midura
M
,
Strunk
A
.
Incidence of hidradenitis suppurativa among tobacco smokers: a population-based retrospective analysis in the U.S.A
.
Br J Dermatol
.
2018
;
178
(
3
):
709
14
.
16.
Zouboulis
CC
,
Del Marmol
V
,
Mrowietz
U
,
Prens
EP
,
Tzellos
T
,
Jemec
GB
.
Hidradenitis Suppurativa/Acne Inversa: Criteria for Diagnosis, Severity Assessment, Classification and Disease Evaluation
.
Dermatology
.
2015
;
231
(
2
):
184
90
.
17.
Pasquereau
A
,
Andler
R
,
Arwidson
P
,
Guignard
R
,
Nguyen-Thanh
V
.
Consommation de tabac parmi les adultes: bilan de cinq années de programme national contre le tabagisme, 2014-2019
.
Bull Epidémiol Hebdom
.
2020
;
14
.
18.
Siddiquee
S
,
Marshman
G
,
Sallis
JA
,
Potter
JA
.
Smoking cessation outcomes in patients with hidradenitis suppurativa: a retrospective analysis
.
Clin Exp Dermatol
.
2021
;
46
(
5
):
945
6
.
19.
Simonart
T
.
Hidradenitis suppurativa and smoking
.
J Am Acad Dermatol
.
2010
;
62
(
1
):
149
50
.
20.
Garg
A
,
Besen
J
,
Legler
A
,
Lam
CS
.
Factors Associated With Point-of-Care Treatment Decisions for Hidradenitis Suppurativa
.
JAMA Dermatol
.
2016
;
152
(
5
):
553
7
.
21.
Vossen
A
,
van Straalen
KR
,
Swolfs
EFH
,
van den Bosch
JF
,
Ardon
CB
,
van der Zee
HH
.
Nicotine Dependency and Readiness to Quit Smoking among Patients with Hidradenitis Suppurativa
.
Dermatology
.
2021
;
237
(
3
):
383
5
.
22.
Canoui-Poitrine
F
,
Le Thuaut
A
,
Revuz
JE
,
Viallette
C
,
Gabison
G
,
Poli
F
, et al
.
Identification of three hidradenitis suppurativa phenotypes: latent class analysis of a cross-sectional study
.
J Invest Dermatol
.
2013
;
133
(
6
):
1506
11
.
23.
Melnik
BC
,
John
SM
,
Chen
W
,
Plewig
G
.
T helper 17 cell/regulatory T-cell imbalance in hidradenitis suppurativa/acne inversa: the link to hair follicle dissection, obesity, smoking and autoimmune comorbidities
.
Br J Dermatol
.
2018
;
179
(
2
):
260
72
.
24.
Hana
A
,
Booken
D
,
Henrich
C
,
Gratchev
A
,
Maas-Szabowski
N
,
Goerdt
S
, et al
.
Functional significance of non-neuronal acetylcholine in skin epithelia
.
Life Sci
.
2007
;
80
(
24–25
):
2214
20
.
25.
Gui
X
,
Yang
Z
,
Li
MD
.
Effect of Cigarette Smoke on Gut Microbiota: State of Knowledge
.
Front Physiol
.
2021
;
12
:
673341
.
26.
Esser
C
,
Rannug
A
,
Stockinger
B
.
The aryl hydrocarbon receptor in immunity
.
Trends Immunol
.
2009
;
30
(
9
):
447
54
.
27.
Zugerman
C
.
Chloracne. Clinical manifestations and etiology
.
Dermatol Clin
.
1990
;
8
(
1
):
209
14
.
28.
Wright
S
,
Strunk
A
,
Garg
A
.
Trends in body mass index before and after diagnosis of hidradenitis suppurativa
.
Br J Dermatol
.
2021
;
185
(
1
):
74
9
.
You do not currently have access to this content.